151. Novel injectable thermosensitive hydrogels for delivering hyaluronic acid-doxorubicin nanocomplexes to locally treat tumors.
- Author
-
Jhan HJ, Liu JJ, Chen YC, Liu DZ, Sheu MT, and Ho HO
- Subjects
- Animals, Antibiotics, Antineoplastic pharmacokinetics, Antibiotics, Antineoplastic therapeutic use, Cell Line, Tumor, Colon drug effects, Colon pathology, Colonic Neoplasms pathology, Doxorubicin pharmacokinetics, Doxorubicin therapeutic use, Humans, Injections, Lymph Nodes drug effects, Lymph Nodes pathology, Male, Mice, Mice, Inbred BALB C, Phase Transition, Temperature, Antibiotics, Antineoplastic administration & dosage, Colonic Neoplasms drug therapy, Delayed-Action Preparations chemistry, Doxorubicin administration & dosage, Hyaluronic Acid chemistry, Hydrogels chemistry, Poloxamer chemistry
- Abstract
Aim: A thermosensitive injectable hydrogel composed of nanocomplexes of doxorubicin and hyaluronic acid (HA) for the local treatment of cancer diseases was developed and characterized., Materials & Methods: It was found that the addition of a divalent metal ion of Mg (MgCl2) was required to properly form HA-doxorubicin nanocomplexes, which were mixed with Pluronic® F127 (BASF, Germany) to form thermosensitive injectable hydrogels., Results: The DH700KMF-15 hydrogel resulted in efficient growth inhibition of C26 colon cancer cells and it selectively targeted the lymphatic system by the specific affinity of HA to the lymphatic system in vivo., Conclusion: The optimal formulations of DH700KMF-15 can increase the therapeutic efficacy of the local treatment of cancer with the potential for lymphotropic targeting to inhibit metastasis.
- Published
- 2015
- Full Text
- View/download PDF